Cannabis/Marijuana for Healthcare

1. Auflage 2022
ISBN: 978-981-16-8824-9
Verlag: Springer Nature Singapore

Buch, Englisch, 319 Seiten, Format (B × H): 155 mm x 235 mm, Gewicht: 517 g

The book contains review articles providing a comprehensive overview of cannabis/marijuana’s diverse healing aspects in human healthcare (medicinal, nutraceutical, skincare, etc.). The research articles include the role of cannabis in cancer treatment, drug discovery, cosmeceutical potential, prophylactic and therapeutic use for treating neuropathic pain and migraine, pharmacokinetics, safety profile, and issues related to the consumption of cannabis/marijuana. Another salient feature of the book is a complete mapping and region- and sector-wise critical analysis of cannabis/marijuana patents on healthcare and future directions for the benefit of researchers and businesses/entrepreneurs interested in the rapidly advancing area of cannabis.

The text describes cannabis/marijuana’s detailed legal aspects, production prospects, and applications for healthcare and recreational purposes in the USA. It traces the traditional roots of cannabis use in Turkey, Israel, the Middle East, Africa, and India.  

This unique compendium of articles will be useful as a reference book for students, researchers, academics, business houses, and all individuals interested in medicinal, nutraceutical, cosmeceutical, traditional, legal, and commercial aspects of cannabis usage.

Zielgruppe

Research

Autoren/Hrsg.

Agrawal, Dinesh Chandra

Dhanasekaran, Muralikrishnan

Kumar, Rajiv

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Biomedizin, Medizinische Forschung, Klinische Studien
• Sozialwissenschaften Psychologie Psychotherapie / Klinische Psychologie

Inhaltsverzeichnis

Chapter 1. A Complete Patent Analysis of Cannabis/Marijuana in Drug Delivery and Disease Conditions.- Chapter 2. Neuropharmacological Approaches to Modulate Cannabinoid Neurotransmission.- Chapter 3. Cannabinoids in Cancer: Cross-talk Between Cannabinoids and miRNAs.- Chapter 4. Cannabis As A Potent Therapeutic Agent For Pharmaceutical Drugs: Recent Advancement In Drug Discovery And Human Healthcare.- Chapter 5. Cannabinoid-Based Innovative Prophylactic and Therapeutic Interventions for Neuropathic Pain and Migraine.- Chapter 6. The Legality of Use and Consumption of Cannabis (Marijuana) in the United States of America.- Chapter 7. Cannabis in Healthcare: Ethnobotanical and Pharmaceutical Perspectives and Legal Status in Turkey and The Middle East.- Chapter 8. Understanding the Pharmacokinetics, Safety Profile, and Scope of the Concerned Issue to Evade the Consumption of Cannabis/Marijuana.- Chapter 9. Traditional Uses of Cannabis in TheMiddle East and The Pathway to Cannabis-Based Healthcare in Israel.- Chapter 10. Traditional and Modern Health Uses of Cannabis sativa L. in Africa and its Phytochemical and Pharmacological Profile.- Chapter 11. Traditional Claims on Cannabis: An Indian and Global Scenario.- Chapter 12. Cannabis (Bhanga) in Classical Text of Ayurveda: An Evidence-Based Rationale.- Chapter 13. Cannabis-Based Cosmetic Products and Their Uses.- Chapter 14. Cannabis as A Unique and Valuable Nutraceutical Formulation for the Current and Future Global Wellbeing.- Chapter 15. Traditional, Cultural, and Nutraceutical Aspects of Cannabis in India.

Über Autor(innen)

Dr. Dinesh Chandra Agrawal, Ph.D., is a professor in the Department of Environmental Engineering & Management and the Department of Applied Chemistry, Chaoyang University of Technology (CYUT), Taiwan. In 2013, he superannuated as a chief scientist and professor of biological sciences after serving for more than 31 years in the Council of Scientific and Industrial Research (CSIR), Ministry of Science and Technology, Govt. of India. He has about 40 years of research experience in plant biotechnology of diverse species, including medicinal plants and mushrooms, and has more than 200 publications, including six books (four by Springer Nature). Professor Agrawal was awarded several prestigious fellowships, including the Alexander von Humboldt Fellowship (Germany), Visiting Scientist to Mississippi State University (USA), British Council Scholar (UK), and European Research Fellow (UK). Since 2016, Professor Agrawal has been serving as associate editor-in-chief of the International Journal of Applied Science and Engineering (Scopus).

Dr. Rajiv Kumar, Ph.D., is a co-founder and executive director of QLEAP Academy, India; former chief scientist and head of Tata Chemicals Innovation Centre, Pune, India; and former head of Catalysis Division, National Chemical Laboratory, Pune.  He has received several awards like the Eminent Scientist Award of the Catalysis Society of India, Chem-Con Distinguished Scientist, Dr. K.G. Naik Gold Medal for Excellence in Chemical Sciences and Technology, Best Scientist of the Year Award of NCL Research Foundation, and Young Scientist Award (Bhattacharya Medal) of the Catalysis Society of India. His areas of interest and expertise include zeolites, catalysis, biosynthesis of nanomaterials, cannabis/hemp, environment, and sustainability. He has approximately 180 papers published in scientific journals and more than 65 patents to his credit. He is/has been a member of the editorialboards of Applied Catalysis-A, Advances in Nano-porous Materials and Pollution Research. He has guided approximately 20 Ph.D. and M.Tech. students.

 Dr. Muralikrishnan Dhanasekaran is a professor at Harrison School of Pharmacy, Auburn University, USA.  He obtained his Ph.D. from the Indian Institute of Chemical Biology, Kolkata, India, and then received his postdoctoral training from renowned scientists Dr. Manuchair Ebadi (University of North Dakota) and Dr. Bala Manyam (Scott & White Clinic/Texas A&M, USA). Dr. Dhanasekaran’s research areas are pharmacology, neuroscience, toxicology, dietary, natural products, and the development of drugs/compounds targeting Alzheimer’s and Parkinson’s disease. Dr. Dhanasekaran completed the New Investigator Research Grant from Alzheimer’s Association, several Auburn University grants, and several other research projects from a pharmaceutical company. Dr. Dhanasekaran has guided 16 students (as a mentor) and currently has 5 graduate students under his leadership, and he has trained more than 50 undergraduate students in his lab. Dr. Dhanasekaran has received several teaching awards from Auburn University. He has published more than 200 scientific abstracts, 103 peer-reviewed publications, 2 books, and several book chapters.